SAN DIEGO, Nov. 7, 2012 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that Dr. Yuichi Iwaki, President and Chief Executive Officer of MediciNova, and Mark Johnson, Director of Investor Relations and Corporate Development of MediciNova, will present a company overview at the Lazard Capital Markets Healthcare Conference on Wednesday, November 14, 2012 at 3:00 p.m. Eastern Time. The conference is being held at The Pierre Hotel in New York City.
